Visceral adipose tissue is associated with insulin resistance in hemodialyzed patients

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 557-562

  Giers, Kinga ^a,b   Niemczyk, Stanisław ^a   Szamotulska, Katarzyna ^c   Romejko Ciepielewska, Katarzyna ^a   Paklerska, Ewa ^b   Bartoszewicz, Zbigniew ^b   Pacho, Ryszard ^b   Jasik, Mariusz ^b   Matuszkiewicz Rowińska, Joanna ^b  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c INSTITUTE OF MOTHER AND CHILD   (Poland)

Author keywords

Adiponectin; Hemodialysis Solutions; Insulin Resistance; Intra Abdominal Fat; Leptin

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; INSULIN; INTERLEUKIN 6; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN; GLUCOSE BLOOD LEVEL;

ACUTE KIDNEY FAILURE; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HOMEOSTASIS AND REGULATION; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MALE; QUANTITATIVE ANALYSIS; UREMIA; BLOOD; CASE CONTROL STUDY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; METABOLISM; MIDDLE AGED; PATHOLOGY;

BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 84923165613     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.892078     Document Type: Article

References (27)

1. Nishizawa Y, Shoji T, Emoto M et al: Roles of metabolic and endocrinological alterations in atherosclerosis and cardiovascular disease in renal failure: another form of metabolic syndrome. Semin Nephrol, 2004; 24: 423–25
2. Smith D, DeFronzo RA: Insulin resistance in uremia mediated by postbinding defects. Kidney Int, 1982; 22: 54–62
3. Niemczyk S, Szamotulska K, Giers K et al: Homeostatic model assessment indices in evaluation of insulin resistance and secretion in hemodialysis patients. Med Sci Monit, 2013; 19: 592–98
4. Guarnieri G, Zanetti M, Vinci P et al: Insulin resistance in chronic uremia. J Ren Nutr, 2009; 19: 20–24
5. Axelsson J, Heimbürger O, Lindholm B, Stenvinkel P: Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr, 2005; 15:131–36
6. Stenvinkel P, Heimbürger O, Lönnqvist F: Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant, 1997; 12: 1321–25
7. Beige J, Heipmann K, Stumvoll M et al: Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiology. Expert Opin Ther Targets, 2009; 13: 163–73
8. Axelsson J, Bergsten A, Qureshi AR et al: Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int, 2006; 69:596–604
9. Atamer A, Alisir Ecder S, Akkus Z et al: Relationship between leptin, insulin resistance, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with chronic kidney disease. J Int Med Res, 2008; 3: 522–28
10. Kobayashi S, Maejima S, Ikeda T, Nagase M: Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant, 2000; 15: 65–70
11. Fliser D, Pacini G, Engelleiter R et al: Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int, 1998; 53: 1343–47
12. Becker B, Kronenberg F, Kielstein JT et al, MMKD Study Group: Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol, 2005; 16: 1091–98
13. Mak RH: Insulin and its role in chronic kidney disease. Pediatr Nephrol, 2008; 23: 355–62
14. Arem R: Hypoglycemia associated with renal failure. Endocrinol Metab Clin North Am, 1989; 18: 103–21
15. Mínguez C, López-Suárez A, Soto MJ et al: [Renal failure and insulin resistance: effect of the dialysis dose.] Rev Clin Esp, 2007; 207: 440–44 [in Spanish]
16. Trirogoff ML, Shintani A, Himmelfarb J, Ikizler TA: Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3–4 chronic kidney disease patients. Am J Clin Nutr, 2007; 86: 1642–48
17. Taskapan MC, Taskapan H, Sahin I et al: Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality. Ren Fail, 2007; 29: 147–54
18. Ziegelmeier M, Bachmann A, Seeger J et al: Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis. Metabolism, 2008; 57: 1414–21
19. Martinez Cantarin MP1, Waldman SA, Doria C et al: The adipose tissue production of adiponectin is increased in end-stage renal disease. Kidney Int, 2013; 83: 487–94
20. Shen YY, Charlesworth JA, Kelly JJ et al: Up-regulation of adiponectin, its isoforms and receptors in end-stage kidney disease. Nephrol Dial Transplant, 2007; 22: 171–78
21. Odamaki M, Furuya R, Ohkawa S et al: Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial Transplant, 1999; 14: 2427–32
22. Shinohara K, Shoji T, Enoto M et al: Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol, 2002; 13: 1894–900
23. Heimbürger O, Lönnqvist F, Danielsson A et al: Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol, 1997; 8: 1423–30
24. Carrero JJ, Cordeiro AC, Lindholm B, Stenvinkel P: The emerging pleiotrophic role of adipokines in the uremic phenotype. Curr Opin Nephrol Hypertens, 2010; 19: 37–42
25. Tamei N, Ogawa T, Ishida H et al: Relationship of high-molecular-weight adiponectin levels to visceral fat accumulation in hemodialysis patients. Intern Med, 2010; 49: 299–305
26. Kurşat S, Colak HB, Toraman A et al: Relationship of insulin resistance in chronic haemodialysis patients with inflammatory indicators, malnutrition, echocardiographic parameters and 24 hour ambulatory blood pressure monitoring. Scand J Urol Nephrol, 2010; 44: 257–64
27. Borazan A, Binici DN: Relationship between insulin resistance and inflammation markers in hemodialysis patients. Ren Fail, 2010; 32: 198–202